[go: up one dir, main page]

DE69926862D1 - Kosmetische oder dermo-pharmazeutische zusammensetzung in form von hydrophoben perlen und herstellungsverfahren - Google Patents

Kosmetische oder dermo-pharmazeutische zusammensetzung in form von hydrophoben perlen und herstellungsverfahren

Info

Publication number
DE69926862D1
DE69926862D1 DE69926862T DE69926862T DE69926862D1 DE 69926862 D1 DE69926862 D1 DE 69926862D1 DE 69926862 T DE69926862 T DE 69926862T DE 69926862 T DE69926862 T DE 69926862T DE 69926862 D1 DE69926862 D1 DE 69926862D1
Authority
DE
Germany
Prior art keywords
cosmetic
beads
dermo
manufacturing
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69926862T
Other languages
English (en)
Other versions
DE69926862T2 (de
Inventor
Karim Ioualalen
Rosanne Raynal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9527477&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69926862(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of DE69926862D1 publication Critical patent/DE69926862D1/de
Application granted granted Critical
Publication of DE69926862T2 publication Critical patent/DE69926862T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Fats And Perfumes (AREA)
DE69926862T 1998-06-17 1999-06-16 Kosmetische oder dermo-pharmazeutische zusammensetzung in form von hydrophoben perlen und herstellungsverfahren Expired - Lifetime DE69926862T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9807612 1998-06-17
FR9807612A FR2779962B1 (fr) 1998-06-17 1998-06-17 Composition cosmetique ou dermopharmaceutique sous forme de perles et procedes pour la preparation
PCT/FR1999/001445 WO1999065448A2 (fr) 1998-06-17 1999-06-16 Composition cosmetique ou dermo-pharmaceutique sous forme de perles et procedes pour la preparation

Publications (2)

Publication Number Publication Date
DE69926862D1 true DE69926862D1 (de) 2005-09-29
DE69926862T2 DE69926862T2 (de) 2006-06-01

Family

ID=9527477

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69926862T Expired - Lifetime DE69926862T2 (de) 1998-06-17 1999-06-16 Kosmetische oder dermo-pharmazeutische zusammensetzung in form von hydrophoben perlen und herstellungsverfahren

Country Status (10)

Country Link
US (1) US6572892B1 (de)
EP (1) EP1030687B1 (de)
AT (1) ATE302614T1 (de)
AU (1) AU4151099A (de)
CA (1) CA2341580C (de)
DE (1) DE69926862T2 (de)
DK (1) DK1030687T3 (de)
ES (1) ES2247804T3 (de)
FR (1) FR2779962B1 (de)
WO (1) WO1999065448A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10161078A1 (de) * 2001-12-12 2003-08-28 Achim Goepferich Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
US6737394B2 (en) * 2002-03-04 2004-05-18 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Isotropic cleansing composition with benefit agent particles
US6858666B2 (en) 2002-03-04 2005-02-22 Aveka, Inc. Organogel particles
FR2852843B1 (fr) * 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
WO2005097061A1 (en) * 2004-04-01 2005-10-20 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
FR2879930B1 (fr) * 2004-12-23 2007-08-31 Oralance Pharma Sa Nouveau systeme galenique pour le transport d'actif, procede de preparation et utilisation
EP1866036A2 (de) * 2005-03-16 2007-12-19 Procyte Corporation Verfahren und zusammensetzungen zur prävention und behandlung von alternder oder lichtgeschädigter haut
US7622132B2 (en) * 2005-06-27 2009-11-24 Elc Management, Llc Encapsulated cosmetic composition
US8236333B2 (en) * 2005-10-19 2012-08-07 Unirem, Inc. Active agent delivery and/or odor retentive composition and methods of use thereof
KR20070044879A (ko) * 2005-10-26 2007-05-02 주식회사 피앤아이 금속, 합금 및 세라믹 나노 입자가 균일하게 진공 증착된파우더의 형성 방법 및 그 제조 장치
FR2913884A1 (fr) * 2007-03-21 2008-09-26 Oralance Pharma Sa Systeme galenique hydrophobe non ionisable
US9145221B2 (en) 2012-03-20 2015-09-29 La Prairie, Inc. Convertible two compartment container
US20160000714A1 (en) 2013-03-06 2016-01-07 Capsugel Belgium Nv Curcumin solid lipid particles and methods for their preparation and use
EP3766480A1 (de) 2014-06-10 2021-01-20 Capsugel Belgium NV Im mund zerfallende tablette mit festen lipidpartikeln und verfahren zu deren herstellung und verwendung
ES2602497T3 (es) 2014-08-14 2017-02-21 Capsugel Belgium Nv Aparato y proceso para verter materiales particulados
WO2016087261A1 (en) 2014-12-04 2016-06-09 Capsugel Belgium N.V. Lipid multiparticulate formulations
WO2016105498A1 (en) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
EP3824908A1 (de) 2015-04-10 2021-05-26 Capsugel Belgium NV Abirateron-acetat-lipidformulierungen
JP2020530494A (ja) 2017-08-07 2020-10-22 フィンチ セラピューティクス、インコーポレイテッド． 健康な腸バリアを維持及び回復するための組成物及び方法
FR3075633B1 (fr) * 2017-12-22 2019-12-06 Lvmh Recherche Compositions cosmetiques comprenant des spheroides anhydres disperses dans une phase siliconee
CA3087569A1 (en) 2018-01-09 2019-07-18 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
CN112203669A (zh) 2018-02-23 2021-01-08 克雷斯顿沃控股公司 微生物组相关的免疫疗法
EP4275761A3 (de) 2018-03-20 2024-02-28 Theriva Biologics, Inc. Alkalische phosphatasemittel zur behandlung von bestrahlungsstörungen
EP3768302A4 (de) 2018-03-20 2021-12-15 Synthetic Biologics, Inc. Intestinale alkalische phosphataseformulierungen
FR3091164B1 (fr) * 2018-12-31 2021-12-10 Lvmh Rech Composition cosmétique solide comprenant des sphéroïdes anhydres en dispersion dans une phase continue aqueuse solide
WO2021011754A1 (en) 2019-07-18 2021-01-21 Synthetic Biologics, Inc. Intestinal alkaline phosphatase-based treatments of metabolic disorders
WO2021016134A1 (en) 2019-07-19 2021-01-28 Spi Pharma, Inc. Preparation of lipophilic active ingredients
CN115944654A (zh) 2019-07-19 2023-04-11 芬奇治疗控股有限责任公司 用于治疗胃肠道病症的方法及产品
EP4028036A1 (de) 2019-09-13 2022-07-20 Finch Therapeutics Holdings LLC Zusammensetzungen und verfahren zur behandlung von störungen aus dem autismusspektrum
WO2021076920A1 (en) 2019-10-16 2021-04-22 Capsugel Belgium Nv Method and composition for increasing muscle protein synthesis
CN115279382A (zh) 2019-10-18 2022-11-01 芬奇治疗控股有限责任公司 用于向受试者递送细菌代谢物的组合物和方法
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
TW202140049A (zh) 2020-01-10 2021-11-01 美商芬奇治療控股有限責任公司 用於治療ｂ型肝炎（ｈｂｖ）及ｄ型肝炎（ｈｄｖ）之組合物及方法
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021202806A1 (en) 2020-03-31 2021-10-07 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
US20240263251A1 (en) 2021-02-19 2024-08-08 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL63127C (de) * 1941-09-02
GB1357731A (en) * 1970-02-12 1974-06-26 Ethichem Ltd Free flowing powder compositions and ointments containing them'
FR2486800A1 (fr) * 1980-07-21 1982-01-22 Oreal Composition cosmetique sous forme d'une creme anhydre de consistance onctueuse
US4800076A (en) * 1987-03-13 1989-01-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions
EP0804249A2 (de) * 1994-03-15 1997-11-05 Brown University Research Foundation Polymeres system zur freisetzung von genen
FR2729077A1 (fr) * 1995-01-05 1996-07-12 Oreal Composition cosmetique sous forme d'une pate souple et procede de preparation
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DK1030687T3 (da) 2006-01-16
WO1999065448A3 (fr) 2000-02-17
ATE302614T1 (de) 2005-09-15
ES2247804T3 (es) 2006-03-01
AU4151099A (en) 2000-01-05
FR2779962A1 (fr) 1999-12-24
WO1999065448A2 (fr) 1999-12-23
DE69926862T2 (de) 2006-06-01
US6572892B1 (en) 2003-06-03
EP1030687A2 (de) 2000-08-30
CA2341580A1 (fr) 1999-12-23
EP1030687B1 (de) 2005-08-24
CA2341580C (fr) 2012-04-10
FR2779962B1 (fr) 2002-12-06

Similar Documents

Publication Publication Date Title
DE69926862D1 (de) Kosmetische oder dermo-pharmazeutische zusammensetzung in form von hydrophoben perlen und herstellungsverfahren
DE69328291D1 (de) Feste kosmetische Zusammensetzung vom Typ Öl-in-Wasser
DE69830095D1 (de) Pharmazeutischer, kosmetischer oder dermo-pharmazeutischer Patch zur Verabreichung mehrerer verschiedenartiger Aktivstoffe
IT1299982B1 (it) Metodo per la realizzazione di pacchetti di sigarette ed impianto per l'attuazione di tale metodo.
DE69423915D1 (de) Dichtgepackte polykationische ammonium, sulfonium und phosphonium lipide
FR2796309B1 (fr) Composition solide et ses utilisations notamment cosmetiques
SE9504077L (sv) Absorberande artikel såsom en blöja med en skålformig absorpstionskropp uppvisande minst en urtagning i form av spår eller kompressionslinjer
DE69032848D1 (de) Dosierungsmittel und dessen Verwendung
ES2194056T3 (es) Uso de almidon para aplicaciones cineticas transdermicas.
IT1295645B1 (it) Apparecchio per l'elettroemanazione di principi attivi.
FR2627385B3 (fr) Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques
ATE226947T1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung
DK0790780T3 (da) Fedtagtig bestanddel
ES2164684T3 (es) Uso de antagonistas de taquiquininas en el tratamiento de emesis.
IT1291710B1 (it) Metodo ed apparecchiatura per la preparazione di film monostrato di particelle o molecole.
ATE208600T1 (de) Verwendung von einer spezifische teilchenphase in kosmetische mitteln
AU8139794A (en) Cosmetic or dermatological oil-in-water emulsions containing amino acids and inorganic pigments
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
ID20967A (id) Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut
FR2642329B1 (fr) Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant
DE69836087D1 (de) Kortikalknochenimplantat für wirbelfusion nach smith-robinson
DE3580227D1 (de) Leukotrien-antagonisten, ihre herstellung und verwendung und pharmazeutische zusammensetzungen, die sie enthalten, und deren herstellung.
FR2652742B1 (fr) Compositions anallergiques cosmetiques et dermo-pharmaceutiques.
ITRM940322A0 (it) "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".
ATE191219T1 (de) Zwischenprodukte und ihre anwendung für die herstellung von n,n'-überbrückten bisindolylmaleimiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MEISSNER, BOLTE & PARTNER GBR, 80538 MUENCHEN

R082 Change of representative

Ref document number: 1030687

Country of ref document: EP

Representative=s name: PATENT- UND RECHTSANWAELTE KRAUS & WEISERT, 80539